These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9829811)
61. Utrophin localization in normal and dystrophin-deficient heart. Pons F; Robert A; Fabbrizio E; Hugon G; Califano JC; Fehrentz JA; Martinez J; Mornet D Circulation; 1994 Jul; 90(1):369-74. PubMed ID: 8026021 [TBL] [Abstract][Full Text] [Related]
62. Relationship between utrophin and regenerating muscle fibers in duchenne muscular dystrophy. Shim JY; Kim TS Yonsei Med J; 2003 Feb; 44(1):15-23. PubMed ID: 12619170 [TBL] [Abstract][Full Text] [Related]
63. Dystrophin immunostaining of muscle from Chinese patients with various neuromuscular diseases. Jong YJ; Chuang YH; Chen SS; Chen BH; Chiang CH J Formos Med Assoc; 1991 Dec; 90(12):1143-8. PubMed ID: 1686882 [TBL] [Abstract][Full Text] [Related]
72. Characterisation of the dystrophin-related protein utrophin in highly purified skeletal muscle sarcolemma vesicles. Ohlendieck K Biochim Biophys Acta; 1996 Sep; 1283(2):215-22. PubMed ID: 8809102 [TBL] [Abstract][Full Text] [Related]
73. Full-length and short forms of utrophin, the dystrophin-related protein. Nguyen TM; Helliwell TR; Simmons C; Winder SJ; Kendrick-Jones J; Davies KE; Morris GE FEBS Lett; 1995 Jan; 358(3):262-6. PubMed ID: 7843413 [TBL] [Abstract][Full Text] [Related]
74. Muscle membrane-skeleton protein changes and histopathological characterization of muscle-eye-brain disease. Auranen M; Rapola J; Pihko H; Haltia M; Leivo I; Soinila S; Virtanen I; Kalimo H; Anderson LV; Santavuori P; Somer H Neuromuscul Disord; 2000 Jan; 10(1):16-23. PubMed ID: 10677859 [TBL] [Abstract][Full Text] [Related]
75. Regeneration in sarcoglycanopathies: expression studies of sarcoglycans and other muscle proteins. Fanin M; Angelini C J Neurol Sci; 1999 Jun; 165(2):170-7. PubMed ID: 10450803 [TBL] [Abstract][Full Text] [Related]
76. Congenital myopathy associated with abnormal accumulation of desmin and dystrophin. Prelle A; Moggio M; Comi GP; Gallanti A; Checcarelli N; Bresolin N; Ciscato P; Fortunato F; Scarlato G Neuromuscul Disord; 1992; 2(3):169-75. PubMed ID: 1483042 [TBL] [Abstract][Full Text] [Related]
77. Immunohistochemical study of utrophin and dystrophin at the motor end-plate in myasthenia gravis. Ito H; Yoshimura T; Satoh A; Takino H; Tsujihata M; Nagataki S Acta Neuropathol; 1996 Jul; 92(1):14-8. PubMed ID: 8811120 [TBL] [Abstract][Full Text] [Related]
78. Cytoplasmic body myopathy: familial cases with accumulation of desmin and dystrophin. An immunohistochemical, immunoelectron microscopic and biochemical study. Caron A; Viader F; Lechevalier B; Chapon F Acta Neuropathol; 1995; 90(2):150-7. PubMed ID: 7484090 [TBL] [Abstract][Full Text] [Related]
79. Supramolecular organization of the subsarcolemmal cytoskeleton of adult skeletal muscle fibers. A review. Berthier C; Blaineau S Biol Cell; 1997 Oct; 89(7):413-34. PubMed ID: 9561721 [TBL] [Abstract][Full Text] [Related]
80. Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders. Finanger Hedderick EL; Simmers JL; Soleimani A; Andres-Mateos E; Marx R; Files DC; King L; Crawford TO; Corse AM; Cohn RD Neurology; 2011 Mar; 76(11):960-7. PubMed ID: 21403107 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]